{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:24:37Z","timestamp":1770780277195,"version":"3.50.0"},"reference-count":83,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vision"],"abstract":"<jats:p>Nitric oxide (NO) is acknowledged as a vital intercellular messenger in multiple systems in the body. Medicine has focused on its functions and therapeutic applications for decades, especially in cardiovascular and nervous systems, and its role in immunological responses. This review was composed to demonstrate the prevalence of NO in components of the ocular system, including corneal cells and multiple cells in the retina. It discussed NO\u2019s assistance during the immune, inflammation and wound-healing processes. NO is identified as a vascular endothelial relaxant that can alter the choroidal blood flow and prompt or suppress vascular changes in age-related macular degeneration and diabetes, as well as the blood supply to the optic nerve, possibly influencing the progression of glaucoma. It will provide a deeper understanding of the role of NO in ocular homeostasis, the delicate balance between overproduction or underproduction and the effect on the processes from aqueous outflow and subsequent intraocular pressure to axial elongation and the development of myopia. This review also recognized the research and investigation of therapies being developed to target the NO complex and treat various ocular diseases.<\/jats:p>","DOI":"10.3390\/vision5020029","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T22:18:29Z","timestamp":1623277109000},"page":"29","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Nitric Oxide Interaction with the Eye"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-0173","authenticated-orcid":false,"given":"Nir","family":"Erdinest","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-3275","authenticated-orcid":false,"given":"Naomi","family":"London","sequence":"additional","affiliation":[{"name":"Private Pracitce, Jerusalem 94228, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Ovadia","sequence":"additional","affiliation":[{"name":"Agnes Ginges, Center for Human Neurogenetics, Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadav","family":"Levinger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel"},{"name":"Enaim Refractive Surgery Center, Jerusalem 9438307, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hirst, D.G., and Robson, T. (2011). Nitric oxide physiology and pathology. Nitric Oxide, Springer.","DOI":"10.1007\/978-1-61737-964-2_1"},{"key":"ref_2","unstructured":"Lancaster, J. (1996). Nitric Oxide: Principles and Actions, Elsevier."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12291-011-0108-4","article-title":"Biochemistry of nitric oxide","volume":"26","author":"Habib","year":"2011","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_4","first-page":"7","article-title":"REVIEW: Nitric Oxide: Actions and Pathological Roles","volume":"1","author":"Dawson","year":"1995","journal-title":"Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","article-title":"Nitric oxide synthases: Roles, tolls, and controls","volume":"78","author":"Nathan","year":"1994","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1096\/fasebj.6.12.1381691","article-title":"Nitric oxide as a secretory product of mammalian cells","volume":"6","author":"Nathan","year":"1992","journal-title":"FASEB J"},{"key":"ref_7","first-page":"109","article-title":"Nitric oxide: Physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S","article-title":"The role of nitric oxide in inflammation and immunity","volume":"41","author":"Clancy","year":"1998","journal-title":"Arthritis Rheum."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/infdis\/167.6.1358","article-title":"Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes","volume":"167","author":"Schneemann","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.4049\/jimmunol.152.8.4110","article-title":"Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide","volume":"152","author":"Vodovotz","year":"1994","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1016\/S0021-9258(17)37600-7","article-title":"Role of transcription factor NF-kappa B\/Rel in induction of nitric oxide synthase","volume":"269","author":"Xie","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V86.3.1184.1184","article-title":"Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages","volume":"86","author":"Weinberg","year":"1995","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1006\/bbrc.1996.0452","article-title":"Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes","volume":"220","author":"Arany","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","first-page":"826","article-title":"Role of nitric oxide synthase isozymes in endotoxin-induced uveitis","volume":"37","author":"Mandai","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0070-2137(96)80006-9","article-title":"Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms","volume":"34","author":"Wink","year":"1996","journal-title":"Curr. Top. Cell Regul."},{"key":"ref_16","first-page":"2045","article-title":"Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokines stimulation","volume":"38","author":"Dighiero","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/niox.1997.0145","article-title":"Transient corneal edema induced by nitric oxide synthase inhibition","volume":"1","author":"Yanagiya","year":"1997","journal-title":"Nitric. Oxide"},{"key":"ref_18","first-page":"1107","article-title":"Interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor gene expression in endotoxin-induced uveitis","volume":"35","author":"Yoshida","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1567-5769(01)00090-X","article-title":"Nitric oxide in parasitic infections","volume":"1","author":"Brunet","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S1567-5769(01)00093-5","article-title":"Nitric oxide and T helper cell immunity","volume":"1","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1600-065X.2000.917307.x","article-title":"The role of nitric oxide in innate immunity","volume":"173","author":"Bogdan","year":"2000","journal-title":"Immunol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0952-7915(99)00052-7","article-title":"Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity","volume":"12","author":"Bogdan","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"ref_23","first-page":"2773","article-title":"Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization","volume":"40","author":"Sennlaub","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00003226-200001000-00017","article-title":"The role of nitric oxide in experimental allergic conjunctivitis","volume":"19","author":"Ko","year":"2000","journal-title":"Cornea"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/112067219800800303","article-title":"Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits","volume":"8","author":"Er","year":"1998","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/exer.1998.0565","article-title":"Production of key molecules by ocular neutrophils early after herpetic infection of the cornea","volume":"67","author":"Daheshia","year":"1998","journal-title":"Exp. Eye Res"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hancock, J.T., and Neill, S.J. (2019). Nitric oxide: Its generation and interactions with other reactive signaling compounds. Plants, 8.","DOI":"10.3390\/plants8020041"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1089\/ars.2020.8161","article-title":"Interplay between Reactive Oxygen\/Reactive Nitrogen Species and Metabolism in Vascular Biology and Disease","volume":"34","author":"Ash","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.niox.2013.10.011","article-title":"Nitric oxide as a regulatory molecule in the processing of the visual stimulus","volume":"36","author":"Lima","year":"2014","journal-title":"Nitric. Oxide"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/iji.12315","article-title":"Polymorphisms in the promoter region of iNOS predispose to rheumatoid arthritis in south Indian Tamils","volume":"44","author":"Negi","year":"2017","journal-title":"Int. J. Immunogenet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0960-9822(00)00443-7","article-title":"Nitric oxide interacts with the retinoblastoma pathway to control eye development in Drosophila","volume":"10","author":"Kuzin","year":"2000","journal-title":"Curr. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kim, J.C., Cheong, T., Park, G., Park, M., Kwon, N., and Yoon, H. (2002). The role of nitric oxide in ocular surface diseases. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3, Springer.","DOI":"10.1007\/978-1-4615-0717-8_96"},{"key":"ref_34","first-page":"1","article-title":"Potential roles of nitrate and nitrite in nitric oxide metabolism in the eye","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3346\/jkms.2002.17.3.389","article-title":"The role of nitric oxide in ocular surface cells","volume":"17","author":"Kim","year":"2002","journal-title":"J. Korean Med. Sci."},{"key":"ref_36","first-page":"36","article-title":"Effect of progesterone on nitric oxide\/cyclic guanosine monophosphate signaling and contraction in gastric smooth muscle cells","volume":"12","author":"Mustafa","year":"2020","journal-title":"Biomed. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2016.05.001","article-title":"The Endothelium-Dependent Nitric Oxide\u2013cGMP Pathway","volume":"Volume 77","author":"Monica","year":"2016","journal-title":"Advances in Pharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"146567","DOI":"10.1016\/j.brainres.2019.146567","article-title":"Choline attenuates inflammatory hyperalgesia activating nitric oxide\/cGMP\/ATP-sensitive potassium channels pathway","volume":"1727","author":"Kusuda","year":"2020","journal-title":"Brain Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12950-015-0104-1","article-title":"Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid","volume":"12","author":"Erdinest","year":"2015","journal-title":"J. Inflamm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-511X-7-37","article-title":"Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules","volume":"7","author":"Das","year":"2008","journal-title":"Lipids Health Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2011.10.045","article-title":"Nitric oxide signaling in the retina: What have we learned in two decades?","volume":"1430","author":"Vielma","year":"2012","journal-title":"Brain Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.exer.2009.10.004","article-title":"Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD)","volume":"90","author":"Bhutto","year":"2010","journal-title":"Exp. Eye Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cant\u00f3, A., Olivar, T., Romero, F.J., and Miranda, M. (2019). Nitrosative Stress in Retinal Pathologies. Antioxidants, 8.","DOI":"10.3390\/antiox8110543"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exer.2017.05.013","article-title":"NO signaling in retinal bipolar cells","volume":"161","author":"Agurto","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_45","first-page":"1","article-title":"Effect of nitric oxide on human corneal epithelial cell viability and corneal wound healing","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_46","first-page":"2106","article-title":"Repeated dosing of NCX 667, a new nitric oxide (NO) donor, retains IOP-lowering activity in animal models of glaucoma","volume":"58","author":"Bastia","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40123-017-0094-6","article-title":"A review of nitric oxide for the treatment of glaucomatous disease","volume":"6","author":"Aliancy","year":"2017","journal-title":"Ophthalmol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62730-4","article-title":"Shear Stress in Schlemm\u2019s canal as a Sensor of intraocular pressure","volume":"10","author":"McDonnell","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_49","first-page":"656","article-title":"Sustained nitric oxide-providing small molecule and precise release behavior study for glaucoma treatment","volume":"17","author":"Jeong","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1167\/iovs.17-22168","article-title":"The ability of nitric oxide to lower intraocular pressure is dependent on guanylyl cyclase","volume":"58","author":"Muenster","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"37127","DOI":"10.1038\/srep37127","article-title":"Caveolin-1 modulates intraocular pressure: Implications for caveolae mechanoprotection in glaucoma","volume":"6","author":"Elliott","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_52","first-page":"144","article-title":"Impaired nitric oxide production in patients with primary open-angle glaucoma","volume":"98","author":"Bouchemi","year":"2020","journal-title":"La Tunis. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddx184","article-title":"Genetics of glaucoma","volume":"26","author":"Wiggs","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Eroglu, E., Bischof, H., Charoensin, S., Waldeck-Weiermaier, M., Graier, W.F., and Malli, R. (2018). Real-time imaging of nitric oxide signals in individual cells using geNOps. Nitric Oxide, Springer.","DOI":"10.1007\/978-1-4939-7695-9_3"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/IJG.0000000000000751","article-title":"The relation between endothelial nitric oxide synthase polymorphisms and normal tension glaucoma","volume":"26","author":"Jeoung","year":"2017","journal-title":"J. Glaucoma"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s12325-015-0260-y","article-title":"Evaluation of the effect of latanoprostene bunod ophthalmic solution, 0.024% in lowering intraocular pressure over 24 h in healthy Japanese subjects","volume":"32","author":"Araie","year":"2015","journal-title":"Adv. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14656566.2017.1293654","article-title":"Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension","volume":"18","author":"Kaufman","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s12325-016-0385-7","article-title":"Long-term safety and efficacy of latanoprostene bunod 0.024% in Japanese subjects with open-angle glaucoma or ocular hypertension: The JUPITER study","volume":"33","author":"Kawase","year":"2016","journal-title":"Adv. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/IJG.0000000000000173","article-title":"Ocular hypertension following intravitreal antivascular endothelial growth factor therapy: Review of the literature and possible role of nitric oxide","volume":"25","author":"Morshedi","year":"2016","journal-title":"J. Glaucoma"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1089\/jop.2016.0188","article-title":"The role of nitric oxide in the intraocular pressure lowering efficacy of latanoprostene bunod: Review of nonclinical studies","volume":"34","author":"Cavet","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1801047","DOI":"10.1002\/adhm.201801047","article-title":"Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma","volume":"7","author":"Hu","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"ref_62","first-page":"568","article-title":"Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma\u2014a review","volume":"17","author":"Venkataraman","year":"2010","journal-title":"Microcirculation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.niox.2018.04.010","article-title":"The nitric oxide-guanylate cyclase pathway and glaucoma","volume":"77","author":"Wareham","year":"2018","journal-title":"Nitric. Oxide"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1604932","DOI":"10.1002\/adma.201604932","article-title":"Localized and controlled delivery of nitric oxide to the conventional outflow pathway via enzyme biocatalysis: Toward therapy for glaucoma","volume":"29","author":"Chandrawati","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2016.11.040","article-title":"The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant","volume":"794","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/bjo.85.12.1426","article-title":"Plasma malondialdehyde and nitric oxide levels in age related macular degeneration","volume":"85","author":"Totan","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1253\/circj.CJ-08-1169","article-title":"Endothelial dysfunction","volume":"73","author":"Vanhoutte","year":"2009","journal-title":"Circ. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ophtha.2011.01.033","article-title":"Endothelin-1 in neovascular AMD","volume":"118","author":"Sakai","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/2008-322X.163765","article-title":"Endothelin-1 and Nitric Oxide levels in exudative age-related macular degeneration","volume":"10","author":"Totan","year":"2015","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_70","first-page":"1","article-title":"Effects of novel nitric oxide-releasing molecules against oxidative stress on retinal pigmented epithelial cells","volume":"2017","author":"Fidilio","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-008-9759-8","article-title":"Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians","volume":"314","author":"Ahluwalia","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/bbrc.1998.8267","article-title":"Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans","volume":"245","author":"Tsukada","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/13816810.2010.497528","article-title":"Endothelial nitric oxide synthase genotypes in the etiology of retinopathy of prematurity in premature infants","volume":"31","author":"Yanamandra","year":"2010","journal-title":"Ophthalmic Genet."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Delmas, D., Cornebise, C., Courtaut, F., Xiao, J., and Aires, V. (2021). New highlights of resveratrol: A review of properties against ocular diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031295"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3341\/kjo.2010.24.2.108","article-title":"Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy","volume":"24","author":"Kim","year":"2010","journal-title":"Korean J. Ophthalmol. KJO"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.preteyeres.2017.06.003","article-title":"Dopamine signaling and myopia development: What are the key challenges","volume":"61","author":"Zhou","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"107956","DOI":"10.1016\/j.exer.2020.107956","article-title":"Increased endogenous dopamine prevents myopia in mice","volume":"193","author":"Landis","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0002-7","article-title":"Nitric oxide (NO) mediates the inhibition of form-deprivation myopia by atropine in chicks","volume":"6","author":"Carr","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00417-019-04573-y","article-title":"Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken","volume":"258","author":"Mathis","year":"2020","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2013.02.007","article-title":"An updated view on the role of dopamine in myopia","volume":"114","author":"Feldkaemper","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1444-0938.2003.tb03123.x","article-title":"The biological basis of myopic refractive error","volume":"86","author":"Morgan","year":"2003","journal-title":"Clin. Exp. Optom."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006324-200402000-00009","article-title":"The effect of the nonspecific nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on the choroidal compensatory response to myopic defocus in chickens","volume":"81","author":"Nickla","year":"2004","journal-title":"Optom. Vis. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1076\/ceyr.16.10.992.9021","article-title":"The effect of nitric oxide synthase inhibitor on form-deprivation myopia","volume":"16","author":"Fujikado","year":"1997","journal-title":"Curr. Eye Res."}],"container-title":["Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2411-5150\/5\/2\/29\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:37Z","timestamp":1760163157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2411-5150\/5\/2\/29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["vision5020029"],"URL":"https:\/\/doi.org\/10.3390\/vision5020029","relation":{},"ISSN":["2411-5150"],"issn-type":[{"value":"2411-5150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]}}}